Safety and efficacy of BAY 94-9027, an extended-half-life factor VIII, during minor surgical procedures in patients with severe haemophilia A

Affiliations

• ¹ Foundation IRCCS Ca' Granda, Maggiore Hospital Policlinico A. Bianchi Bonomi Hemophilia and Thrombosis Center, Milan, Italy.
• ² Israel National Hemophilia Center, Chaim Sheba Medical Center, Tel Hashomer, Israel.
• ³ Sackler School of Medicine, Tel-Aviv University, Tel Hashomer, Israel.
• ⁴ Center for Bleeding and Clotting Disorders, University of Minnesota Medical Center, Minneapolis, MN, USA.
• ⁵ Hemophilia Treatment Center, UC Davis Medical Center, Sacramento, CA, USA.
• ⁶ Department of Haematology, Singapore General Hospital, Singapore.
• ⁷ The Haemophilia Centre, Aarhus University Hospital, Aarhus, Denmark.
• ⁸ Bayer, Whippany, NJ, USA.